Literature DB >> 23024289

Antenatal spectrum of CHARGE syndrome in 40 fetuses with CHD7 mutations.

Marine Legendre1, Marie Gonzales, Géraldine Goudefroye, Frédéric Bilan, Pauline Parisot, Marie-José Perez, Maryse Bonnière, Bettina Bessières, Jelena Martinovic, Anne-Lise Delezoide, Frédérique Jossic, Catherine Fallet-Bianco, Martine Bucourt, Julia Tantau, Philippe Loget, Laurence Loeuillet, Nicole Laurent, Brigitte Leroy, Houria Salhi, Nicole Bigi, Caroline Rouleau, Fabien Guimiot, Chloé Quélin, Anne Bazin, Caroline Alby, Amale Ichkou, Roselyne Gesny, Alain Kitzis, Yves Ville, Stanislas Lyonnet, Ferechte Razavi, Brigitte Gilbert-Dussardier, Michel Vekemans, Tania Attié-Bitach.   

Abstract

BACKGROUND: CHARGE syndrome is a rare, usually sporadic disorder of multiple congenital anomalies ascribed to a CHD7 gene mutation in 60% of cases. Although the syndrome is well characterised in children, only one series of 10 fetuses with CHARGE syndrome has been reported to date. Therefore, we performed a detailed clinicopathological survey in our series of fetuses with CHD7 mutations, now extended to 40 cases. CHARGE syndrome is increasingly diagnosed antenatally, but remains challenging in many instances.
METHOD: Here we report a retrospective study of 40 cases of CHARGE syndrome with a CHD7 mutation, including 10 previously reported fetuses, in which fetal or neonatal clinical, radiological and histopathological examinations were performed.
RESULTS: Conversely to postnatal studies, the proportion of males is high in our series (male to female ratio 2.6:1) suggesting a greater severity in males. Features almost constant in fetuses were external ear anomalies, arhinencephaly and semicircular canal agenesis, while intrauterine growth retardation was never observed. Finally, except for one, all other mutations identified in our antenatal series were truncating, suggesting a possible phenotype-genotype correlation.
CONCLUSIONS: Clinical analysis allowed us to refine the clinical description of CHARGE syndrome in fetuses, describe some novel features and set up diagnostic criteria in order to help the diagnosis of CHARGE syndrome after termination of pregnancies following the detection of severe malformations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23024289     DOI: 10.1136/jmedgenet-2012-100926

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Authors:  Joseph A Micucci; Wanda S Layman; Elizabeth A Hurd; Ethan D Sperry; Sophia F Frank; Mark A Durham; Donald L Swiderski; Jennifer M Skidmore; Peter C Scacheri; Yehoash Raphael; Donna M Martin
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

Review 2.  Inner ear manifestations in CHARGE: Abnormalities, treatments, animal models, and progress toward treatments in auditory and vestibular structures.

Authors:  Daniel I Choo; Kareem O Tawfik; Donna M Martin; Yehoash Raphael
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-10-30       Impact factor: 3.908

Review 3.  Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.

Authors:  Joseph A Micucci; Ethan D Sperry; Donna M Martin
Journal:  Stem Cells Dev       Date:  2015-02-25       Impact factor: 3.272

4.  Cerebellar Heterotopias: Expanding the Phenotype of Cerebellar Dysgenesis in CHARGE Syndrome.

Authors:  J N Wright; J Rutledge; D Doherty; F Perez
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

5.  Rescue of neural crest-derived phenotypes in a zebrafish CHARGE model by Sox10 downregulation.

Authors:  Zainab Asad; Aditi Pandey; Aswini Babu; Yuhan Sun; Kaivalya Shevade; Shruti Kapoor; Ikram Ullah; Shashi Ranjan; Vinod Scaria; Ruchi Bajpai; Chetana Sachidanandan
Journal:  Hum Mol Genet       Date:  2016-07-13       Impact factor: 6.150

6.  Occipital teratoma in a neonate with CHARGE syndrome: a case report.

Authors:  Emily Anderson; Robert S Heller; Knarik Arkun; Jesse Winer
Journal:  Childs Nerv Syst       Date:  2019-12-04       Impact factor: 1.475

7.  CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia.

Authors:  Glenn E Green; Farhan S Huq; Sarah B Emery; Suresh K Mukherji; Donna M Martin
Journal:  Otol Neurotol       Date:  2014-09       Impact factor: 2.311

8.  The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development.

Authors:  Ethan D Sperry; Elizabeth A Hurd; Mark A Durham; Elyse N Reamer; Adam B Stein; Donna M Martin
Journal:  Dev Dyn       Date:  2014-07-10       Impact factor: 3.780

9.  Identification of novel pathogenic variants and novel gene-phenotype correlations in Mexican subjects with microphthalmia and/or anophthalmia by next-generation sequencing.

Authors:  Diana Matías-Pérez; Leopoldo A García-Montaño; Marisa Cruz-Aguilar; Iván A García-Montalvo; Jessica Nava-Valdéz; Tania Barragán-Arevalo; Cristina Villanueva-Mendoza; Camilo E Villarroel; Clavel Guadarrama-Vallejo; Rocío Villafuerte-de la Cruz; Oscar Chacón-Camacho; Juan C Zenteno
Journal:  J Hum Genet       Date:  2018-09-04       Impact factor: 3.172

Review 10.  Congenital heart defects in CHARGE: The molecular role of CHD7 and effects on cardiac phenotype and clinical outcomes.

Authors:  Joshua K Meisner; Donna M Martin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-13       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.